ea0089c39 | Clinical – Surgery/Applied Pathology | NANETS2022
E McElroy, MD Katherine
, Irfan, MD Ahmer
, Reddy, MD Sushanth
, Yates, PhD Clayton
, Chen, MD, FACS Herbert
, Bart Rose, MD J.
Background: Pancreatic neuroendocrine tumors (pNETs) are slow growing, malignant tumors that show different survival outcomes by race. They are often diagnosed in late stages, with few treatments available. PNETs are the second most common pancreatic cancer and are rapidly increasing in incidence. Current size-based guidelines were largely developed in White patients and recently have been called into question for Black patients. We investigated differences of primary tumor si...